Literature DB >> 30890517

[Structure and function of B-cell linker and its role in the development of B cell-related diseases].

Bin Xiao1, Jiaying Li2, Mengsi Zhou2, Xiaoqing Li1, Xiaoyan Huang1, Jianfeng Hang1, Zhaohui Sun1, Linhai Li1.   

Abstract

B cell linker (BLNK) is a key linker protein of B cell receptor (BCR) signaling pathway. BLNK participates in the regulation of PLC-γactivity and the activation of Ras pathway through its typical structure and interaction network with other proteins, and is thus widely involved in the regulation of B cell proliferation, differentiation, apoptosis and signal transduction. Furthermore, it is closely related to anaphylactic diseases, multiple sclerosis, chromosomal aneuploidy, aneuglobulinemia, B lymphocytic leukemia and lymphoma. Herein we review the structure and biological function of BLNK and its role in B cell-related diseases. BLNK can cooperate with a series of effective proteins to activate BCR signaling pathway, thereby regulating the development, maturation and function of B cells. The functional mutation of BLNK can destroy the homeostasis of B cells and affect the development and maturation of B cells, which leads to the occurrence of B cell related diseases. A comprehensive understanding of the biological functions of BLNK not only provides insights into the pathogenesis of B cell-related diseases, but also inspires new ideas and helps to find breakthroughs for the treatment of these diseases with BLNK as the therapeutic target.

Entities:  

Keywords:  B cell receptor; B cell-related diseases; B-cell linker; differentiation; signaling pathway

Mesh:

Substances:

Year:  2019        PMID: 30890517      PMCID: PMC6765629          DOI: 10.12122/j.issn.1673-4254.2019.02.20

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  29 in total

Review 1.  Btk and BLNK in B cell development.

Authors:  S Tsukada; Y Baba; D Watanabe
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

2.  Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia.

Authors:  Rolla F Abu-Arja; Leah R Chernin; Ghada Abusin; Jeffery Auletta; Linda Cabral; Rachel Egler; Hans D Ochs; Troy R Torgerson; Jesus Lopez-Guisa; Robert W Hostoffer; Haig Tcheurekdjian; Kenneth R Cooke
Journal:  Pediatr Blood Cancer       Date:  2015-04-20       Impact factor: 3.167

3.  The B cell receptor promotes B cell activation and proliferation through a non-ITAM tyrosine in the Igalpha cytoplasmic domain.

Authors:  Heide Christine K Patterson; Manfred Kraus; You-Me Kim; Hidde Ploegh; Klaus Rajewsky
Journal:  Immunity       Date:  2006-07       Impact factor: 31.745

Review 4.  FOXO1 transcription factor: a critical effector of the PI3K-AKT axis in B-cell development.

Authors:  Maciej Szydłowski; Ewa Jabłońska; Przemysław Juszczyński
Journal:  Int Rev Immunol       Date:  2014-02-20       Impact factor: 5.311

5.  An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.

Authors:  Jonathan C Poe; Wei Jia; Hsuan Su; Sarah Anand; Jeremy J Rose; Prasanthi V Tata; Amy N Suthers; Corbin D Jones; Pei Fen Kuan; Benjamin G Vincent; Jonathan S Serody; Mitchell E Horwitz; Vincent T Ho; Steven Z Pavletic; Frances T Hakim; Kouros Owzar; Dadong Zhang; Bruce R Blazar; Christian W Siebel; Nelson J Chao; Ivan Maillard; Stefanie Sarantopoulos
Journal:  Blood       Date:  2017-08-29       Impact factor: 22.113

6.  B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.

Authors:  Naoto Imoto; Fumihiko Hayakawa; Shingo Kurahashi; Takanobu Morishita; Yuki Kojima; Takahiko Yasuda; Keiki Sugimoto; Shinobu Tsuzuki; Tomoki Naoe; Hitoshi Kiyoi
Journal:  J Biol Chem       Date:  2015-12-24       Impact factor: 5.157

Review 7.  Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental models.

Authors:  Rehana Z Hussain; Liat Hayardeny; Petra C Cravens; Felix Yarovinsky; Todd N Eagar; Benjamine Arellano; Krystin Deason; Cyd Castro-Rojas; Olaf Stüve
Journal:  J Neuroimmunol       Date:  2014-08-30       Impact factor: 3.478

8.  Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins.

Authors:  Nupur Gupta; Jeffrey Delrow; Amar Drawid; Anirvan M Sengupta; Gaofeng Fan; Céline Gélinas
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

9.  Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis.

Authors:  Zhixing Kuang; Li Guo; Xun Li
Journal:  Mol Med Rep       Date:  2017-08-03       Impact factor: 2.952

10.  Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.

Authors:  Casey D S Katerndahl; Lynn M Heltemes-Harris; Mark J L Willette; Christine M Henzler; Seth Frietze; Rendong Yang; Hilde Schjerven; Kevin A T Silverstein; Laura B Ramsey; Gregory Hubbard; Andrew D Wells; Roland P Kuiper; Blanca Scheijen; Frank N van Leeuwen; Markus Müschen; Steven M Kornblau; Michael A Farrar
Journal:  Nat Immunol       Date:  2017-04-03       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.